Mesalazine granule formulation improves clinical data in Crohn's disease compared with tablet formulation
Abstract The efficacy of sustained-release preparations of mesalazine as a remission maintenance treatment for Crohn's disease remains to be established. We aimed to examine the changes in compliance rate and clinical data 2 years after switching from mesalazine tablet to granule formulation at...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/51034e09db5b4b42b964b2e511743e39 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|